It has also been documented that the expression of CART is decreased in the CSF of AD patients, and the treatment of exogenous CART can partially ameliorate the deficits of learning and memory in mice [58] by improving the synaptic ultrastructure [59]. This evidence concerns the gene CARTPT and Alzheimer disease.